In Severe allergic reactions Dianora 1mg Injection is used along with emergency medical treatment to treat life-threatening allergic reactions caused by insect bites or stings, foods, medications, latex, and other causes. It reduces allergic reactions by reducing inflammatory response caused by the release of a chemical called histamine, that is responsible for various symptoms of allergic reactions like shortness of breath, hives, swelling, inflammation etc. In Cardiac arrest Dianora 1mg Injection contains a hormone called adrenaline, that stimulates the heart and promotes blood flow. It is a proven life-saving treatment for people whose heart s have stopped working all of a sudden due to an emergency condition called cardiac arrest. Its action is fast though it has a very short duration of action. It is given in an emergency condition to save life by a trained healthcare professional only.
It is not known whether it is safe to consume alcohol with Dianora 1mg Injection. Please consult your doctor.
Dianora 1mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Dianora 1mg Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Dianora 1mg Injection does not usually affect your ability to drive.
There is limited information available on the use of Dianora 1mg Injection in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Dianora 1mg Injection in patients with liver disease. Please consult your doctor.
If you miss a dose of Dianora 1mg Injection, please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Suncure Lifescience Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Swiss Parenterals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Neon Laboratories Ltd || ₹14.5/tablet (25% cheaper)